Alexion Pharmaceuticals, Inc.
Leonard Bell, M.D. —Chief Executive Officer
Stephen Squinto, Ph.D. — Executive Vice President and Head of Research & Development
David Hallal — Executive Vice President and Chief Commercial Officer
Vikas Sinha — Executive Vice President and Chief Financial Officer
Clare Carmichael — Senior Vice President, Chief Human Resources Officer
John Moriarty — Senior Vice President, General Counsel
Frank Wright — Senior Vice President, API President, APIS
Camille Bedrosian M.D. — Senior Vice President and Chief Medical Officer
Thomas Bock M.D., M.B.A. — Senior Vice President, Global Medical Affairs
M. Stacy Hooks, Ph.D. — Senior Vice President, Technical Operations
Claude Nicaise M.D. — Senior Vice President, Strategic Product Development & Global Regulatory Affairs
Heidi Wagner Esq. — Senior Vice President, Global Government Affairs
Claus Weisemann Ph.D. — Senior Vice President, Corporate Quality and Compliance
James Bilotta M.B.A. — Vice President and Chief Information Officer
Daniel Caron — Vice President, Site Operations and Engineering
Sven Ante(Bill) Lundberg M.D. — Vice President and Head of Translational Medicine
Margaret Olinger, M.B.A — Vice President, Global Hematology Franchise
Jeremy Springhorn Ph.D. — Vice President, Corporate Strategy and Business Development
Jeroen van Beek Ph.D. — Vice-President, Global Nephrology Franchise
Leonard Bell, M.D. — Chief Executive Officer
Max Link, Ph.D. — Chairman of the Board of Directors
William Keller — Director
Joseph A. Madri, Ph.D., M.D. — Director
Larry Mathis — Director
R. Douglas Norby — Director
Alvin S. Parven — Director
Andreas Rummelt, Ph.D. — Director
Ann Veneman — Director